HPV検査の世界市場2016-2020

◆英語タイトル:Global HPV Testing Market 2016-2020
◆商品コード:IRTNTR11106
◆発行会社(調査会社):Technavio
◆発行日:2016年12月13日
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、HPV検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、HPV検査の世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About HPV Testing
According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample taken from the cervix.

Technavio’s analysts forecast the global HPV testing market to grow at a CAGR of 16.17% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global HPV testing market for 2016-2020. To calculate the market size, the report considers only the HPV test products used for genital cancer screening such as cervical cancer.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global HPV Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Laboratories
• BD
• Roche Diagnostics
• Qiagen

[Other prominent vendors]
• Arbor Vita
• Breakspear Medical
• Cepheid
• DAAN Gene
• DiaCarta
• Delphi Bioscience
• Fujirebio Diagnostics
• Genera Biosystems
• IncellDx
• OralDNA Labs
• Seegene
• SoloPap
• Trovagene

[Market driver]
• Early detection of cervical cancer to prevent the growing prevalence
• For a full, detailed list, view our report

[Market challenge]
• Pap test: Alternative diagnostic tests for cervical cancer screening
• For a full, detailed list, view our report

[Market trend]
• Expansion of companies in key markets
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of Contents
PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Cervical cancer diagnosis by HPV testing

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Global HPV testing market by systems
• Global HPV testing market by consumables

PART 07: Market segmentation by end-user
• Hospitals
• Clinical diagnostic laboratories
• Physicians’ office laboratories

PART 08: Geographical segmentation
• HPV testing market in Americas
• HPV testing market in EMEA
• HPV testing market in APAC

PART 09: Market drivers
• Early detection of cervical cancer to prevent the growing prevalence
• Paradigm shift toward use of HPV home-testing kits
• Reimbursements for HPV tests

PART 10: Impact of drivers

PART 11: Market challenges
• Pap test: Alternative diagnostic test for cervical cancer screening
• Limited number of health clinics and healthcare settings in developing countries
• Lack of uniformity in screening policies

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Expansion of companies in key markets
• Co-testing with HPV and Pap tests
• Development of mRNA HPV test

PART 14: Vendor landscape
• Competitive landscape analysis

PART 15: Key vendor analysis
• Abbott Laboratories
• BD
• Roche Diagnostics
• Qiagen
• Hologic
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Market dynamics: Global HPV testing market
Exhibit 03: Global HPV testing market 2015-2020 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global HPV testing market by product 2015 and 2020
Exhibit 06: Market overview: Global HPV testing market by systems
Exhibit 07: Global HPV testing market by systems 2015-2020 ($ millions)
Exhibit 08: PEST analysis: Global HPV testing market by systems
Exhibit 09: Market overview: Global HPV testing market by consumables
Exhibit 10: Global HPV testing market by consumables 2015-2020 ($ millions)
Exhibit 11: PEST analysis: Global HPV testing market by consumables
Exhibit 12: Global HPV testing market by end-users 2015
Exhibit 13: Revenue generated by diagnostic and medical laboratories in US 2009-2014 ($ millions)
Exhibit 14: Global HPV testing market by geography in 2015 and 2020 ($ millions)
Exhibit 15: Americas: Market overview of HPV testing
Exhibit 16: Comparative percentage of women aged between 20 and 69 who participated in cervical cancer screening in Americas (2003 and 2013)
Exhibit 17: HPV testing market in Americas 2015-2020 ($ millions)
Exhibit 18: HPV testing market in Americas: Analysis in various countries
Exhibit 19: Key takeaway: HPV testing market in the US
Exhibit 20: PEST analysis: HPV testing market in the US
Exhibit 21: Differences: HPV testing guidelines for cervical cancer testing
Exhibit 22: EMEA: market overview of HPV testing
Exhibit 23: Percentage of women aged 20-69 participated in cervical cancer screening in EMEA in different countries (2003 and 2013)
Exhibit 24: HPV testing market in EMEA 2015-2020 ($ millions)
Exhibit 25: HPV testing market in EMEA: Analysis in various countries
Exhibit 26: Key takeaway: HPV testing market in the UK
Exhibit 27: PEST analysis: HPV testing market in the UK
Exhibit 28: APAC: market overview of HPV testing
Exhibit 29: HPV testing market in APAC 2015-2020 ($ millions)
Exhibit 30: HPV testing market in EMEA: Analysis in various countries
Exhibit 31: Estimated number of cervical cancer in women at different age groups 2014
Exhibit 32: Market impact analysis: HPV home-testing kits
Exhibit 33: Impact of drivers
Exhibit 34: Lack of uniformity in cervical cancer screening intervals in EMEA
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Market impact analysis: companies in key market
Exhibit 37: Market analysis: Companies focusing on mRNA HPV test
Exhibit 38: Competitive structure analysis of global HPV testing market 2015
Exhibit 39: Competitive landscape analysis of global HPV testing market 2015
Exhibit 40: Market penetration of various HPV testing manufacturing companies in global (2015)
Exhibit 41: Game changing factors for companies to focus on the market
Exhibit 42: Abbott Laboratories strength assessment
Exhibit 43: Abbott Laboratories strategy assessment
Exhibit 44: Abbott Laboratories opportunity assessment
Exhibit 45: BD strength assessment
Exhibit 46: BD strategy assessment
Exhibit 47: BD opportunity assessment
Exhibit 48: Roche Diagnostics strength assessment
Exhibit 49: Roche Diagnostics strategy assessment
Exhibit 50: Roche Diagnostics opportunity assessment
Exhibit 51: Qiagen strength assessment
Exhibit 52: Qiagen strategy assessment
Exhibit 53: Qiagen opportunity assessment
Exhibit 54: Hologic strength assessment
Exhibit 55: Hologic strategy assessment
Exhibit 56: Hologic opportunity assessment
Exhibit 57: Other prominent vendors
Exhibit 58: Product matrix: HPV testing market analysis



【掲載企業】

Abbott Laboratories, BD, Roche Diagnostics, Qiagen, Arbor Vita, Breakspear Medical, Cepheid, DAAN Gene, DiaCarta, Delphi Bioscience, Fujirebio Diagnostics, Genera Biosystems, IncellDx, OralDNA Labs, Seegene, SoloPap, Trovagene.

【レポートのキーワード】

ヒトパピローマウイルス、HPV検査機器、HPV検査消耗品

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[HPV検査の世界市場2016-2020]販売に関する免責事項
★調査レポート[HPV検査の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆